Ground Swell Capital’s Passage Bio PASG Stock Holding History

Ground Swell Capital’s Portfolio PASG Stock Details PASG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,271	Closed	-$14.4K	–	229
2024 Q4	$14.4K	Buy	+1,271	New	+$16.6K	0.02%	128

Other funds holding PASG

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ground Swell Capital's PASG Position: Q1 2025 in Review

Ground Swell Capital sold out of Passage Bio (PASG) in Q1 2025, closing a stake of 1,271 shares — an estimated $14.4K sold.

Ground Swell Capital first reported a position in PASG in Q4 2024 and held it in 1 quarter. The position peaked at $14.4K in Q4 2024. 41 funds tracked by Wall St. Rank hold PASG as of Q1 2025.

Ground Swell Capital reported no remaining Passage Bio position as of Q1 2025 after selling out during the quarter.
Ground Swell Capital sold 1,271 Passage Bio shares in Q1 2025, an estimated $14.4K.
Ground Swell Capital first reported a position in Passage Bio in Q4 2024 and held it in 1 quarter.
Ground Swell Capital's Passage Bio position peaked at $14.4K in Q4 2024.
41 funds tracked by Wall St. Rank held Passage Bio as of Q1 2025.

Based on Ground Swell Capital's 13F filing for Q1 2025, filed 13 May 2025.